ResMed Inc. Reports Strong Market Position in 2024
Decoding ResMed Inc (RMD): A Strategic SWOT Insight
10-K: FY2024 Annual Report
ResMed Shares Breathing Life Into Big Money Portfolios
Resmed Insider Sold Shares Worth $3,145,905, According to a Recent SEC Filing
ResMed (RMD) Is a Top-Ranked Momentum Stock: Should You Buy?
Citi Remains a Hold on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Top Brokers Name 3 ASX Shares to Buy Today 7 August 2024
ResMed(RMD.US) Officer Sells US$10.42 Million in Common Stock
42 High-quality, Low Beta Stocks to Better 'Sleep at Night' - BofA
ResMed Bull Lifts Forecasts on 4Q Margin Surprise -- Market Talk
Form 144 | ResMed(RMD.US) Officer Proposes to Sell 10.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 5, $RESMED INC CDI COM USD0.004 (10CDI/1SHS)(RSMDF.US)$、$ResMed(RMD.US)$ Officer Leong Justin intends to sell 48,000 shares of its common stock on Aug 5, with a total
Express News | Resmed Inc : UBS Raises Target Price to $225 From $210
DJ Australian Equities Roundup -- Market Talk
ResMed Shares Hit 52-Week High After Reporting Strong Results on Friday
Resmed Inc Reports Increased CDI Issuance
ResMed's 4Q EPS Beat Drives Improved Outlook -- Market Talk
Morgans Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed Target Price Raised 12% to A$40.25/Share by Wilsons>RMD.AU